Te Arai Biofarma

Te Arai Biofarma is owned by Sonoma Pharmaceuticals.

Sonoma Pharmaceuticals is a company listed under the stock ticker SNOA (US).

Sonoma Pharmaceuticals has a direct presence in 2 countries.

View the org chart displaying its 4 main executives

Most searched biographies at Te Arai Biofarma

• Jennifer Gravatt, Director
• Lance Gravatt, Chairman of the Board
• Scott Lissington, Director

Create your alert
to follow the executive moves at Te Arai Biofarma.

Sonoma Pharmaceuticals has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Te Arai Biofarma

Social media about Te Arai Biofarma

• Te Arai Biofarma on Wikipedia, Google News & Yahoo Finance
• Te Arai Biofarma on LinkedIn, Twitter & YouTube

Contact by email its executives including Lance Gravatt

Call Te Arai Biofarma at +64 27...

View the org chart

Register to receive your alert

Report an error